Findings

What do systematic reviews say?

262 questions · 309 findings · 35 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 66 · 21.4%GRADE not reported 46 · 14.9%Very low 85 · 27.5%Low 60 · 19.4%Moderate 38 · 12.3%High 14 · 4.5%

Adjunct cognitive behavioural therapy vs adjunct supportive psychotherapy

Depressive symptoms · patients with delusional disorder

1 finding from 1 review

Treatments for delusional disorder 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 17 participants
Low

Adjunct cognitive behavioural therapy vs adjunct supportive psychotherapy

Anxiety · patients with delusional disorder

1 finding from 1 review

Treatments for delusional disorder 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 17 participants
Low

Adjunct cognitive behavioural therapy vs adjunct supportive psychotherapy

Service use: Admitted · patients with delusional disorder

The review found no eligible studies for this question.

1 finding from 1 review

Treatments for delusional disorder 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Adjunct cognitive behavioural therapy vs adjunct supportive psychotherapy

Social function: Self worth ‐ average score Social Self‐Esteem Inventory · patients with delusional disorder

1 finding from 1 review

Treatments for delusional disorder 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 17 participants
Very low

Adjunct cognitive behavioural therapy vs adjunct supportive psychotherapy

Adverse effects: Leaving the study early · patients with delusional disorder

Adjunct cognitive behavioural therapy showed no clear difference in adverse event: Leaving the study early compared with adjunct supportive psychotherapy (moderate certainty).

1 finding from 1 review

Treatments for delusional disorder 2015 · Cochrane Headline outcomes only
RR 0.17 [0.02, 1.18]
1 study · 24 participants
Moderate

Anti‐epileptic drugs vs other anti‐epileptic drugs

Early seizures (number of seizures) · people with traumatic head injuries

Anti‐epileptic drugs showed no clear difference in early seizure Counts of events compared with other anti‐epileptic drugs (low certainty).

1 finding from 1 review

Pharmacological treatments for preventing epilepsy following traumatic head injury 2015 · Cochrane Headline outcomes only
RR 0.66 [0.2, 2.12]
2 studies · 431 participants
Low

Anti‐epileptic drugs vs other anti‐epileptic drugs

Late seizures (number of seizures) · people with traumatic head injuries

Anti‐epileptic drugs showed no clear difference in late seizure Counts of events compared with other anti‐epileptic drugs (moderate certainty).

1 finding from 1 review

Pharmacological treatments for preventing epilepsy following traumatic head injury 2015 · Cochrane Headline outcomes only
RR 0.77 [0.46, 1.3]
2 studies · 378 participants
Moderate

Anti‐epileptic drugs vs other anti‐epileptic drugs

All‐cause mortality · people with traumatic head injuries

Anti‐epileptic drugs showed no clear difference in all‐cause mortality compared with other anti‐epileptic drugs (moderate certainty).

1 finding from 1 review

Pharmacological treatments for preventing epilepsy following traumatic head injury 2015 · Cochrane Headline outcomes only
RR 0.53 [0.3, 94]
2 studies · 431 participants
Moderate

Anti‐epileptic drugs vs other anti‐epileptic drugs

Any serious adverse event of treatment · people with traumatic head injuries

1 finding from 1 review

Pharmacological treatments for preventing epilepsy following traumatic head injury 2015 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Anti‐epileptic drugs vs other anti‐epileptic drugs

Seizures · people with traumatic head injuries

1 finding from 1 review

Pharmacological treatments for preventing epilepsy following traumatic head injury 2015 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Antiseptic mouthwash (e.g. chlorhexidine) vs Another topical agent or placebo

Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers

The review found no eligible studies for this question.

1 finding from 1 review

Topical treatments for HIV‐related oral ulcers 2012 · Cochrane All outcomes
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…
0 studies
No studies found

Topical thalidomide vs Another topical agent or placebo

Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers

The review found no eligible studies for this question.

1 finding from 1 review

Topical treatments for HIV‐related oral ulcers 2012 · Cochrane All outcomes
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…
0 studies
No studies found

Topical corticosteroids vs Another topical agent or placebo

Duration to heal oral ulcerations after initiation of treatment · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers

The review found no eligible studies for this question.

1 finding from 1 review

Topical treatments for HIV‐related oral ulcers 2012 · Cochrane All outcomes
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…
0 studies
No studies found

Antiseptic mouthwash (e.g. chlorhexidine) vs Another topical agent or placebo

Duration to heal oral ulcerations after initiation of treatment · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers

The review found no eligible studies for this question.

1 finding from 1 review

Topical treatments for HIV‐related oral ulcers 2012 · Cochrane All outcomes
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…
0 studies
No studies found

Topical thalidomide vs Another topical agent or placebo

Incidence and recurrence after healing of ulcers · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers

The review found no eligible studies for this question.

1 finding from 1 review

Topical treatments for HIV‐related oral ulcers 2012 · Cochrane All outcomes
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…
0 studies
No studies found

Topical corticosteroids vs Another topical agent or placebo

Healing of ulceration · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers

The review found no eligible studies for this question.

1 finding from 1 review

Topical treatments for HIV‐related oral ulcers 2012 · Cochrane All outcomes
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…
0 studies
No studies found

Antiseptic mouthwash (e.g. chlorhexidine) vs Another topical agent or placebo

Healing of ulceration · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers

The review found no eligible studies for this question.

1 finding from 1 review

Topical treatments for HIV‐related oral ulcers 2012 · Cochrane All outcomes
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…
0 studies
No studies found

Topical corticosteroids vs Another topical agent or placebo

Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers

The review found no eligible studies for this question.

1 finding from 1 review

Topical treatments for HIV‐related oral ulcers 2012 · Cochrane All outcomes
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…
0 studies
No studies found

Antiseptic mouthwash (e.g. chlorhexidine) vs Another topical agent or placebo

Incidence and recurrence after healing of ulcers · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers

The review found no eligible studies for this question.

1 finding from 1 review

Topical treatments for HIV‐related oral ulcers 2012 · Cochrane All outcomes
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…
0 studies
No studies found

Topical corticosteroids vs Another topical agent or placebo

Adverse effects of long‐term use of available topical agents · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers

The review found no eligible studies for this question.

1 finding from 1 review

Topical treatments for HIV‐related oral ulcers 2012 · Cochrane All outcomes
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…
0 studies
No studies found